Bill Type
Long Title
AN ACT TO MAKE THE LAWS ON PATENTS, TRADENAMES AND TRADEMARKS MORE RESPONSIVE TO THE HEALTH CARE NEEDS OF THE FILIPINO PEOPLE BY CLARIFYING NON-PATENTABLE INVENTIONS, ALLOWING THE IMPORTATION AND EARLY DEVELOPMENT OF PATENTED MEDICINES, AND MODIFYING GOVERNMENT USE PROVISIONS FOR DRUGS AND MEDICINES, TO LOWER PRICES AND INCREASE ACCESS TO AND SUPPLY OF QUALITY DRUGS AND MEDICINES, AMENDING FOR THIS PURPOSE CERTAIN PROVISIONS OF REPUBLIC ACT NO. 8293, OTHERWISE KNOWN AS THE INTELLECTUAL PROPERTY CODE OF THE PHILIPPINES
Date filed
August 22, 2006
Scope

Legislative History

House Bill/Resolution NO. HB05718
FULL TITLE : AN ACT TO MAKE THE LAWS ON PATENTS, TRADENAMES AND TRADEMARKS MORE RESPONSIVE TO THE HEALTH CARE NEEDS OF THE FILIPINO PEOPLE BY CLARIFYING NON-PATENTABLE INVENTIONS, ALLOWING THE IMPORTATION AND EARLY DEVELOPMENT OF PATENTED MEDICINES, AND MODIFYING GOVERNMENT USE PROVISIONS FOR DRUGS AND MEDICINES, TO LOWER PRICES AND INCREASE ACCESS TO AND SUPPLY OF QUALITY DRUGS AND MEDICINES, AMENDING FOR THIS PURPOSE CERTAIN PROVISIONS OF REPUBLIC ACT NO. 8293, OTHERWISE KNOWN AS THE INTELLECTUAL PROPERTY CODE OF THE PHILIPPINES
ABSTRACT : The bill seeks to allow the parallel importation of drugs as a tool for price reduction and introduce the Bolar provision in the Intellectual Property Code which would accelerate the production of generics.
PRINCIPAL AUTHOR/S : ANA THERESIA "RISA" HONTIVEROS-BARAQUEL
DATE FILED : 2006-08-22
SIGNIFICANCE: NATIONAL
CO-AUTHORS :
1. Rosales 2. Aguja
CO-AUTHORS (Journal Entries) :
1. Nantes (019 )
ACTIONS TAKEN BY THE COMMITTEE
MOTHER BILL: HB06035
ACTIONS TAKEN BY THE COMMITTEE ON RULES
REFERRAL TO THE COMMITTEE ON TRADE AND INDUSTRY ON 2006-08-23

Abstract

The bill seeks to allow the parallel importation of drugs as a tool for price reduction and introduce the Bolar provision in the Intellectual Property Code which would accelerate the production of generics.'

Disclaimer

Note: Legislative history and other information accessed from Congress Legis. Information as of April 20, 2022.